Documents
Application Sponsors
Marketing Status
Application Products
001 | SOLUTION/DROPS;OPHTHALMIC | 0.1% | 1 | ALPHAGAN P | BRIMONIDINE TARTRATE |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 2005-08-19 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2010-08-13 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 7 | AP | 2013-06-05 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 8 | AP | 2014-03-12 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 9 | AP | 2014-01-22 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 10 | AP | 2016-05-05 | STANDARD |
Submissions Property Types
SUPPL | 4 | Null | 6 |
SUPPL | 7 | Null | 0 |
SUPPL | 8 | Null | 0 |
SUPPL | 9 | Null | 0 |
SUPPL | 10 | Null | 0 |
TE Codes
CDER Filings
ALLERGAN
cder:Array
(
[0] => Array
(
[ApplNo] => 21770
[companyName] => ALLERGAN
[docInserts] => ["",""]
[products] => [{"drugName":"ALPHAGAN P","activeIngredients":"BRIMONIDINE TARTRATE","strength":"0.1%","dosageForm":"SOLUTION\/DROPS;OPHTHALMIC","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"08\/13\/2010","submission":"SUPPL-4","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/021262s020,021770s004lbl.pdf\"}]","notes":""},{"actionDate":"08\/19\/2005","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/021770lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"ALPHAGAN P","submission":"BRIMONIDINE TARTRATE","actionType":"0.1%","submissionClassification":"SOLUTION\/DROPS;OPHTHALMIC","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
[supplements] =>
[actionDate] => 2010-08-13
)
)